S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
RBOT · VICARIOUS SURGICAL INC COM CL A NEW
OTC MARKETS - BOATS Real Time Price • USD
$1.99
-0.01
(-0.75%)
● At close: March 2 at 4:00:00 PM EDT
DAY'S RANGE
$1.99
$1.96
$2.04
52-WEEK RANGE
$1.99
$0.00
$6.28
What's happening
- RBOT is down 0.75% today, trading at $1.99. — Live quote
- Volume today (2,929) is well below its 3-month average of 53,340. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-1.57 actual vs. $-1.40 estimated (-12.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 0
Hold 3
Sell 1
Strong sell 2
Aggregate ratings for 2026-08-01 (6 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
RBOT
-99.98%
vs S&P 500
-112.55%
1-YEAR RETURN
RBOT
-99.99%
vs S&P 500
-114.55%
6-MONTH RETURN
RBOT
-99.95%
3-MONTH RETURN
RBOT
-99.76%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-01-26 (Q4 2025)
$-1.57
Est. $-1.40
MISS -12.4%
2025-10-26 (Q3 2025)
$-1.86
Est. $-2.37
BEAT +21.6%
2025-07-26 (Q2 2025)
$-2.23
Est. $-2.55
BEAT +12.4%
2025-04-26 (Q1 2025)
$-2.60
Est. $-2.53
MISS -2.8%
Valuation Measures & Ratios
Enterprise Value4-$893.4K
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)0.01
Price / Book71.44
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin—
Operating Margin—
Return on Equity (ROE8)-333.19%
Return on Assets (ROA9)-164.51%
Avg Volume (3M)53,340
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short175,182
Change from Prior Settlement+144.86%
% of Float—
Days to Cover (Short Ratio)1.07
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-07-21; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Trailing 52-week price return is -100.0%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on RBOT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$11.5M | -$13.5M | -$15.7M | -$17.8M | -$17.7M | -$16.1M | -$21.4M | -$21.5M |
| Net income | -$11.1M | -$13.2M | -$15.4M | -$17.1M | -$15.2M | -$17.0M | -$15.7M | -$15.3M |
| EPS (diluted) | — | — | — | — | $-2.59 | $-0.10 | $-0.10 | $-3.62 |
| EPS (basic) | — | — | — | — | $-2.59 | $-0.10 | $-0.10 | $-3.62 |
Balance sheet
| Line item | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $19.6M | $29.3M | $40.9M | $55.1M | $67.7M | $80.6M | $93.3M | $105.3M |
| Total liabilities | $9.7M | $15.3M | $17.8M | $21.0M | $21.0M | $22.7M | $21.5M | $21.3M |
| Stockholders' equity | $9.8M | $14.1M | $23.1M | $34.1M | $46.7M | $57.9M | $71.9M | $84.0M |
| Total current assets | $11.6M | $15.1M | $26.1M | $39.7M | $51.7M | $64.0M | $75.9M | $87.1M |
| Total current liabilities | $3.9M | $3.2M | $5.1M | $7.9M | $7.7M | $8.6M | $7.2M | $5.1M |
| Cash & equivalents | $2.6M | $3.2M | $3.9M | $2.6M | $9.7M | $7.1M | $20.2M | $38.2M |
| Marketable securities (current) | $7.2M | $10.2M | $20.1M | $34.8M | $39.4M | $53.8M | $53.0M | $45.9M |
| Property, plant & equipment | $1.3M | $3.5M | $3.8M | $4.1M | $4.5M | $4.8M | $5.3M | $5.9M |
| Other non-current assets | $29.0K | $39.0K | $21.0K | $31.0K | $49.0K | $89.0K | $132.0K | $105.0K |
| Accounts payable | $894.0K | $915.0K | $721.0K | $1.0M | $1.2M | $2.4M | $1.4M | $1.3M |
| Accrued liabilities | $1.1M | $905.0K | $3.1M | $5.6M | $5.3M | $5.0M | $4.7M | $2.7M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | — | — | — | — | — | — | — | — |
| Retained earnings | -$246.1M | -$235.6M | -$224.5M | -$211.3M | -$195.9M | -$182.0M | -$164.9M | -$149.7M |
| Accumulated other comprehensive income (loss) | $4.0K | $8.0K | — | $18.0K | $50.0K | $124.0K | -$51.0K | -$41.0K |
Cash flow
| Line item | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9.3M | -$10.5M | -$13.5M | -$11.8M | -$11.8M | -$12.7M | -$11.0M | -$14.5M |
| Investing cash flow | $3.0M | $9.7M | $14.8M | $4.6M | $14.4M | -$492.0K | -$7.0M | -$144.0K |
| Financing cash flow | $5.7M | $26.0K | $24.0K | $17.0K | $6.0K | $0 | $0 | $2.0K |
| Free cash flow | -$9.4M | — | -$13.5M | -$11.8M | -$12.0M | — | -$11.0M | -$14.5M |
| Capital expenditures | $127.0K | — | $0 | $5.0K | $164.0K | — | $6.0K | $10.0K |
| Depreciation & amortization | — | $352.0K | $413.0K | — | — | $507.0K | $524.0K | — |
| Share-based compensation | $1.1M | $2.0M | $2.2M | $2.8M | $2.8M | $2.9M | $3.1M | $3.1M |
| Change in accounts payable | -$10.0K | $275.0K | -$392.0K | -$145.0K | -$233.0K | $40.0K | $83.0K | $14.0K |
| Purchases of investments | $6.4M | $3.9M | $2.1M | $8.9M | $5.4M | $13.9M | $19.4M | $19.5M |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating income | -$50.0M | -$66.6M | -$80.7M | -$80.1M | -$38.2M |
| Net income | -$50.2M | -$63.2M | -$71.1M | $5.2M | -$35.2M |
| EPS (diluted) | — | — | $-0.49 | $0.04 | $-0.36 |
| EPS (basic) | — | — | $-0.49 | $0.04 | $-0.36 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $19.6M | $67.7M | $119.9M | $140.3M | $181.7M |
| Total liabilities | $9.7M | $21.0M | $21.9M | $29.2M | $98.6M |
| Stockholders' equity | $9.8M | $46.7M | $98.0M | $111.0M | $83.1M |
| Total current assets | $11.6M | $51.7M | $101.0M | $120.4M | $178.4M |
| Total current liabilities | $3.9M | $7.7M | $7.3M | $8.4M | $6.2M |
| Cash & equivalents | $2.6M | $9.7M | $52.8M | $116.2M | $173.5M |
| Marketable securities (current) | $7.2M | $39.4M | $45.4M | — | — |
| Property, plant & equipment | $1.3M | $4.5M | $6.4M | $6.6M | $2.2M |
| Other non-current assets | $29.0K | $49.0K | $114.0K | $92.0K | — |
| Accounts payable | $894.0K | $1.2M | $1.3M | $1.7M | $1.5M |
| Accrued liabilities | $1.1M | $5.3M | $5.0M | $5.8M | $4.1M |
| Short-term debt | — | — | — | — | — |
| Long-term debt | — | — | $2.0M | — | — |
| Common stock & paid-in capital | — | — | — | $11.0K | $10.0K |
| Retained earnings | -$246.1M | -$195.9M | -$132.7M | -$61.6M | -$66.8M |
| Accumulated other comprehensive income (loss) | $4.0K | $50.0K | $10.0K | — | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$45.1M | -$50.0M | -$62.3M | -$61.2M | -$33.3M |
| Investing cash flow | $32.1M | $6.9M | -$45.8M | -$5.4M | -$1.3M |
| Financing cash flow | $5.8M | $8.0K | $44.7M | $9.1M | $192.2M |
| Free cash flow | -$45.2M | -$50.1M | -$64.0M | -$66.6M | -$34.6M |
| Capital expenditures | $132.0K | $180.0K | $1.7M | $5.4M | $1.3M |
| Share-based compensation | $8.1M | $11.9M | $13.3M | $12.3M | $3.7M |
| Change in accounts payable | -$272.0K | -$96.0K | -$473.0K | $135.0K | $1.1M |
| Purchases of investments | $21.3M | $58.1M | $75.7M | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding RBOT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-06-03 to 2026-02-20
Recent transactions
- Most recent: Sachs Adam David (President) — Open market sale of 942 shares on 2026-02-20.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Sachs Adam David | President | Open market sale | 2026-02-20 | 942 |
| Khalifa Sammy | Chief Technology Officer | Open market sale | 2026-02-20 | 754 |
| Tang Donald F | Director | Open market sale | 2025-08-26 | 2,753 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-02-20 | Sachs Adam David | President | Open market sale | 942 | $2.09 |
| 2026-02-20 | Khalifa Sammy | Chief Technology Officer | Open market sale | 754 | $2.08 |
| 2025-12-03 | Sachs Adam David | President | Open market sale | 463 | $2.95 |
| 2025-12-03 | Khalifa Sammy | Chief Technology Officer | Open market sale | 239 | $2.97 |
| 2025-11-20 | Khalifa Sammy | Chief Technology Officer | Open market sale | 653 | $2.74 |
| 2025-11-20 | Sachs Adam David | President | Open market sale | 816 | $2.71 |
| 2025-09-03 | Sachs Adam David | President | Open market sale | 463 | $5.76 |
| 2025-09-03 | Khalifa Sammy | Chief Technology Officer | Open market sale | 239 | $5.72 |
| 2025-08-26 | Tang Donald F | Director | Open market sale | 2,753 | $6.70 |
| 2025-08-20 | Khalifa Sammy | Chief Technology Officer | Open market sale | 653 | $6.04 |
| 2025-08-20 | Sachs Adam David | President | Open market sale | 817 | $6.03 |
| 2025-08-20 | Tang Donald F | Director | Open market sale | 2,059 | $6.04 |
| 2025-08-19 | Tang Donald F | Director | Open market sale | 100 | $6.68 |
| 2025-06-23 | Sachs Adam David | CEO | Open market sale | 279 | $7.80 |
| 2025-06-23 | Khalifa Sammy | Chief Technology Officer | Open market sale | 223 | $7.81 |
| 2025-06-03 | Khalifa Sammy | Chief Technology Officer | Open market sale | 239 | $7.25 |
| 2025-06-03 | Sachs Adam David | CEO | Open market sale | 463 | $7.22 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 22:59 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-07-21 | 8-K | 2026-07-21 | View on SEC.gov → |
| 2026-06-24 | 8-K | 2026-06-24 | View on SEC.gov → |
| 2026-04-30 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-04-08 | 8-K | 2026-04-08 | View on SEC.gov → |
| 2026-03-09 | 8-K | 2026-03-09 | View on SEC.gov → |
| 2026-03-09 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-03-06 | 8-K | 2026-03-04 | View on SEC.gov → |
| 2026-03-04 | 8-K | 2026-03-03 | View on SEC.gov → |
| 2026-02-24 | 4 | 2026-02-20 | View on SEC.gov → |
| 2026-02-24 | 4 | 2026-02-20 | View on SEC.gov → |
| 2026-02-02 | 8-K | 2026-02-01 | View on SEC.gov → |
| 2026-01-09 | 8-K | 2026-01-09 | View on SEC.gov → |
Recent news
Headlines about RBOT (VICARIOUS SURGICAL INC COM CL A NEW). Links open the publisher — we don’t host full articles.
-
Vicarious Surgical (RBOT) Stock Price, News & Analysis $RBOT
MarketBeat · 2026-10-21 -
Time runs out for Vicarious Surgical
Yahoo Finance · 2026-07-22 -
SS Innovations International (SSII) Appoints Sarah Romano as Chief Financial Officer
Yahoo Finance · 2026-07-15 -
Vicarious Surgical board proposes dissolving the company
Yahoo Finance · 2026-07-15 -
SS Innovations names Sarah Romano as CFO
Yahoo Finance · 2026-07-15 -
Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting
Yahoo Finance · 2026-05-13 -
Vicarious Surgical GAAP EPS of -$1.03
Seeking Alpha · 2026-04-30 -
Vicarious Surgical Reports First Quarter 2026 Financial Results
Yahoo Finance · 2026-04-30
No headlines in this category right now — try “All”.